HOSPITAL BASED CANCER REGISTRY Kidwai Memorial Institute of Oncology, Bangalore

Transcription

1 HOSPITAL BASED CANCER REGISTRY Kidwai Memorial Institute of Oncology, Dr.P.S.Prabhakaran, MBBS, MS. Director, Kidwai Memorial Institute of Oncology, & Principal Investigator Mr.K.Ramachandra Reddy Co-Principal Investigator and Professor & Head Dr. C. Ramesh Assistant Professor Mr.K.Mani Lecturer Department of Biostatistics and Cancer Registry The Kidwai Memorial Institute of Oncology is a comprehensive centre for cancer research and treatment in Karnataka and is one of the Regional Cancer Centres in the country, offering sophisticated diagnostic and treatment services to ever increasing numbers of the cancer afflicted from all over Karnataka State and adjoining areas of Andhra Pradesh, Tamil Nadu, Kerala, Maharashtra and Goa. THe Institute started in 1973 with just 50 beds currently has 429 inpatient beds. Everyday new patients and more than 650 follow-up patients visit the hospital. The Institute being a referral cancer centre and in view of the facilities available, about 70 percent of the patients are referred by various medical institutions and private practitioners. Over 13,000 new cases are registered annually and about 1.90 lakhs follow-up patients are registered each year. More than 18% of patients are registered annually are from the adjacent states of Andhra Pradesh, Tamil Nadu, Maharashtra and Kerala. The Hospital Based Cancer Registry was started at Kidwai Memorial Institute of Oncology in Medical Records section was part of the registry and reporting of data was limited to the number of cases by site and sex. The Indian Council of Medical Research, as part of expansion activity of National Cancer Registry Programme, included this registry under its network in 1984 and thus has continued to contribute data to NCRP for the past 15 years. D:\Ncrp\.p65 137

2 Functions of the Department The Faculty of the Department is involved in teaching Biostatistics and Cancer Epidemiological methods to the students of super specialty courses in the institute, Post Graduate and Under Graduates of various disciplines. In addition, the faculty provides statistical consultation to many research projects. The Registry Component of the department collects information on socio-demographic and life style habits from every patient on their registration. Subsequently, the data on clinical aspects such as Diagnosis, clinical extent /stage of the disease, treatment details, disease status at discharge etc. are abstracted from the case sheets on to the core proforma of NCRP. The data so collected is computerized with the software developed by the department to carryout the necessary quality checks. The data analysis is carried out and reports are generated every year, which will help the institute for administrative purposes, academic and research activities and assisting in Cancer Control activities. Based on the observations made from the registry report(s), three case control studies were conducted. The Case Control study on Oesophageal cancer (in collaboration with ICMR) was completed and the results with detailed report was submitted to ICMR. The results on the cast control study of Breast Cancers will be published in the near future. The data collection is in progress for case control study on ovarian cancers. Other Staff of Hospital Based Cancer Registry, Mr.D.J.Jayaram : Senior Investigator Mr.C.Shivanna : Assistant Social Scientist (transferred to MCDU) Mr.V.Bhadraiah : Assistant Social Scientist Mr.A.V.Srinivasa Gowda : Assistant Social Scientist Mr.R.Lingaraju : Assistant Social Scientist Mr.M.K.M.Gowda : Assistant Social Scientist Mrs.B.J.Kumudini : Assistant Social Scientist Mr.Balakrishnoji Rao : Field/Medico Social Worker (transferred from MCDU) Mr.A.Subramani : Coding Clerk Mrs.A.K.Jyothi : Stenographer Mr.V.M.Mahadevappa : Attender 138

3 Table: BLR - 1(a): Number of Cancers by Site (ICD-9) and 5 Year Age Group: Males ANS=Age Not Specified ; %= Relative Proportion of Cancers of All Sites. ICD-9 Site ANS Total % 140 Lip Tongue Salivary Glands Gum Floor Of Mouth Other Mouth Oropharynx Nasopharynx Hypopharynx Pharynx Etc Oesophagus Stomach Small Intes Colon Rectum Liver Gall Bladder Pancreas Retroperit Other Dig. Sys Nasal Cavity Larynx Lung Pleura Thymus Other Resp Bone Conn. Tiss Skin Melanoma Skin Other Breast Male Prostate Testis Penis Etc Uri. Bladder Kidney Eye Brain Nervous Sy Thyroid Gland Oth. Endo. Glands Ill Def. Site Sec. Lymph Node Sec. Res. Etc Sec. Other Prim. Unknown Lymphosarcoma Hodgkin's Disease Oth. Lymphoma Multi. Myeloma Leuk. Lymphatic Leuk. Myelocytic Leuk. Monocytic Leuk. Misc Leuk. Unspecified All Sites D:\Ncrp\.p65 139

4 Table: BLR - 1(b): Number of Cancers by Site (ICD-9) and 5 Year Age Group: Females ANS=Age Not Specified ; %= Relative Proportion of Cancers of All Sites. ICD-9 Site ANS Total % 140 Lip Tongue Salivary Glands Gum Floor Of Mouth Other Mouth Oropharynx Nasopharynx Hypopharynx Pharynx Etc Oesophagus Stomach Small Intes Colon Rectum Liver Gall Bladder Pancreas Retroperit Other Dig. Sys Nasal Cavity Larynx Lung Pleura Thymus Other Resp Bone Conn. Tiss Skin Melanoma Skin Other Breast Uterus Nos Cervix Placenta Body Uterus Ovary Vagina Uri. Bladder Kidney Eye Brain Nervous Sy Thyroid Gland Oth. Endo. Glands Ill Def. Site Sec. Lymph Node Sec. Res. Etc Sec. Other Prim. Unknown Lymphosarcoma Hodgkin's Disease Oth. Lymphoma Multi. Myeloma Leuk. Lymphatic Leuk. Myelocytic Leuk. Monocytic Leuk. Misc Leuk. Unspecified All Sites

5 Table: BLR - 2 (a): Number (#) and Proportion (%) of Cancers by Site (ICD-9) and Method of Diagnosis Males ICD-9 Site Clinical Microscopic X - Ray Others Total # % # % # % # % # % 140 Lip Tongue Salivary Glands Gum Floor Of Mouth Other Mouth Oropharynx Nasopharynx Hypopharynx Pharynx Etc Oesophagus Stomach Small Intes Colon Rectum Liver Gall Bladder Pancreas Retroperit Other Dig. Sys Nasal Cavity Larynx Lung Pleura Thymus Other Resp Bone Conn. Tiss Skin Melanoma Skin Other Breast Male Prostate Testis Penis Etc Uri. Bladder Kidney Eye Brain Nervous Sy Thyroid Gland Oth. Endo. Glands Ill Def. Site Sec. Lymph Node Sec. Res. Etc Sec. Other Prim. Unknown Lymphosarcoma Hodgkin's Disease Oth. Lymphoma Multi. Myeloma Leuk. Lymphatic Leuk. Myelocytic Leuk. Monocytic Leuk. Misc Leuk. Unspecified All Sites D:\Ncrp\.p65 141

6 Table: BLR - 2(b): Number (#) and Proportion (%) of Cancers by Site (ICD-9) and Method of Diagnosis Females ICD-9 Site Clinical Microscopic X - Ray Others Total # % # % # % # % # % 140 Lip Tongue Salivary Glands Gum Floor Of Mouth Other Mouth Oropharynx Nasopharynx Hypopharynx Pharynx Etc Oesophagus Stomach Small Intes Colon Rectum Liver Gall Bladder Pancreas Retroperit Other Dig. Sys Nasal Cavity Larynx Lung Pleura Thymus Other Resp Bone Conn. Tiss Skin Melanoma Skin Other Breast Uterus Nos Cervix Placenta Body Uterus Ovary Vagina Uri. Bladder Kidney Eye Brain Nervous Sy Thyroid Gland Oth. Endo. Glands Ill Def. Site Sec. Lymph Node Sec. Res. Etc Sec. Other Prim. Unknown Lymphosarcoma Hodgkin's Disease Oth. Lymphoma Multi. Myeloma Leuk. Lymphatic Leuk. Myelocytic Leuk. Monocytic Leuk. Misc Leuk. Unspecified All Sites

7 Table: BLR - 3(a): Number (#) and Proportion (%) of Cancers by Site (ICD-9) and Detailed Microscopic Diagnosis Males ICD-9 Site Pri. Hist Sec. Hist Cytology Blood Film Bone Marrow Others Total # % # % # % # % # % # % # % 140 Lip Tongue Salivary Glands Gum Floor of Mouth Other Mouth Oropharynx Nasopharynx Hypopharynx Pharynx Etc Oesophagus Stomach Small Intes Colon Rectum Liver Gall Bladder Pancreas Retroperito Other Dig. Sys Nasal Cavity Larynx Lung Pleura Thymus Other Resp Bone Conn. Tiss Skin Melanoma Skin Other Breast Male Prostate Testis Penis Etc Uri. Bladder Kidney Eye Brain Nervous Sy Thyroid Gland Oth. Endo. Glands Ill Def. Site Sec. Lymph Node Sec. Res. Etc Sec. Other Prim. Unknown Lymphosarcoma Hodgkin's Disease Oth. Lymphoma Mult. Myeloma Leuk. Lymphatic Leuk. Myelocytic Leuk. Monocytic Leuk. Oth. Sp Leuk. Unspecified All Sites D:\Ncrp\.p65 143

8 Table: BLR - 3(b): Number (#) and Proportion (%) of Cancers by Site (ICD-9) and Detailed Microscopic Diagnosis Females ICD-9 Site Pri. Hist Sec. Hist Cytology Blood Film Bone Marrow Others Total # % # % # % # % # % # % # % 140 Lip Tongue Salivary Glands Gum Floor of Mouth Other Mouth Oropharynx Nasopharynx Hypopharynx Pharynx Etc Oesophagus Stomach Small Intes Colon Rectum Liver Gall Bladder Pancreas Retroperito Other Dig. Sys Nasal Cavity Larynx Lung Pleura Thymus Other Resp Bone Conn. Tiss Skin Melanoma Skin Other Breast Female Uterus Nos Cervix Placenta Body Uterus Ovary Vagina Uri. Bladder Kidney Eye Brain Nervous Sy Thyroid Gland Oth. Endo. Glands Ill Def. Site Sec. Lymph Node Sec. Res. Etc Sec. Other Prim. Unknown Lymphosarcoma Hodgkin's Disease Oth. Lymphoma Mult. Myeloma Leuk. Lymphatic Leuk. Myelocytic Leuk. Monocytic Leuk. Oth. Sp Leuk. Unspecified All Sites

9 Table: BLR - 4(a): Number (#) and Proportion (%) of Cancers by Site (ICD-9) and Broad Treatment Group Males ICD-9 Site Prior Tmt. Prior+at RI Only at RI No CDT* Total # % # % # % # % # % 140 Lip Tongue Salivary Glands Gum Floor Of Mouth Other Mouth Oropharynx Nasopharynx Hypopharynx Pharynx Etc Oesophagus Stomach Small Intes Colon Rectum Liver Gall Bladder Pancreas Retroperit Other Dig. Sys Nasal Cavity Larynx Lung Pleura Thymus Other Resp Bone Conn. Tiss Skin Melanoma Skin Other Breast Male Prostate Testis Penis Etc Uri. Bladder Kidney Eye Brain Nervous Sy Thyroid Gland Oth. Endo. Glands Ill Def. Site Sec. Lymph Node Sec. Res. Etc Sec. Other Prim. Unknown Lymphosarcoma Hodgkin's Disease Oth. Lymphoma Multi. Myeloma Leuk. Lymphatic Leuk. Myelocytic Leuk. Monocytic Leuk. Misc Leuk. Unspecified All Sites * : Cancer Directed Treatment D:\Ncrp\.p65 145

10 Table: BLR - 4(b): Number (#) and Proportion (%) of Cancers by Site (ICD-9) and Broad Treatment Group Females ICD-9 Site Prior Tmt. Prior+at RI Only at RI No CDT* Total # % # % # % # % # % 140 Lip Tongue Salivary Glands Gum Floor Of Mouth Other Mouth Oropharynx Nasopharynx Hypopharynx Pharynx Etc Oesophagus Stomach Small Intes Colon Rectum Liver Gall Bladder Pancreas Retroperit Other Dig. Sys Nasal Cavity Larynx Lung Pleura Thymus Other Resp Bone Conn. Tiss Skin Melanoma Skin Other Breast Uterus Nos Cervix Placenta Body Uterus Ovary Vagina Uri. Bladder Kidney Eye Brain Nervous Sy Thyroid Gland Oth. Endo. Glands Ill Def. Site Sec. Lymph Node Sec. Res. Etc Sec. Other Prim. Unknown Lymphosarcoma Hodgkin's Disease Oth. Lymphoma Multi. Myeloma Leuk. Lymphatic Leuk. Myelocytic Leuk. Monocytic Leuk. Misc Leuk. Unspecified All Sites * : Cancer Directed Treatment 146

11 Table: BLR - 5(a): Number (#) and Proportion (%) of Cancers by Site (ICD-9) and Clinical Extent of Disease (Excluding the Cancers Previously Treated) Males ICD-9 Site Localised Regional Distant Others Unknown Total # % # % # % # % # % # % 140 Lip Tongue Salivary Glands Gum Floor of Mouth Other Mouth Oropharynx Nasopharynx Hypopharynx Pharynx Etc Oesophagus Stomach Small Intes Colon Rectum Liver Gall Bladder Pancreas Retroperito Other Dig. Sys Nasal Cavity Larynx Lung Pleura Thymus Other Resp Bone Conn. Tiss Skin Melanoma Skin Other Breast Male Prostate Testis Penis Etc Uri. Bladder Kidney Eye Brain Nervous Sy Thyroid Gland Oth. Endo. Glands Ill Def. Site Sec. Lymph Node Sec. Res. Etc Sec. Other Prim. Unknown Lymphosarcoma Hodgkin's Disease Oth. Lymphoma Mult. Myeloma Leuk. Lymphatic Leuk. Myelocytic Leuk. Monocytic Leuk. Oth. Sp Leuk. Unspecified All Sites D:\Ncrp\.p65 147

12 Table: BLR - 5(b): Number (#) and Proportion (%) of Cancers by Site (ICD-9) and Clinical Extent of Disease (Excluding the Cancers Previously Treated) Females ICD-9 Site Localised Regional Distant Others Unknown Total # % # % # % # % # % # % 140 Lip Tongue Salivary Glands Gum Floor of Mouth Other Mouth Oropharynx Nasopharynx Hypopharynx Pharynx Etc Oesophagus Stomach Small Intes Colon Rectum Liver Gall Bladder Pancreas Retroperito Other Dig. Sys Nasal Cavity Larynx Lung Pleura Thymus Other Resp Bone Conn. Tiss Skin Melanoma Skin Other Breast Female Uterus Nos Cervix Placenta Body Uterus Ovary Vagina Uri. Bladder Kidney Eye Brain Nervous Sy Thyroid Gland Oth. Endo. Glands Ill Def. Site Sec. Lymph Node Sec. Res. Etc Sec. Other Prim. Unknown Lymphosarcoma Hodgkin's Disease Oth. Lymphoma Mult. Myeloma Leuk. Lymphatic Leuk. Myelocytic Leuk. Monocytic Leuk. Oth. Sp Leuk. Unspecified All Sites

13 Table: BLR - 6(a): Number (#) and Proportion (%) of Cancers by Site (ICD-9) and Type of Treatment at Reporting Institution (Excluding the Cancers Previously Treated) Males R-Therapy = Radiotherapy, C-Therapy = Chemotherapy ICD-9 Surgery (S) R-Therapy C-Therapy S+R S+C R+C S+R+C Others Unknown Total Site # % # % # % # % # % # % # % # % # % # % All D:\Ncrp\.p65 149

14 Table: BLR - 6(b): Number (#) and Proportion (%) of Cancers by Site (ICD-9) and Type of Treatment at Reporting Institution (Excluding the Cancers Previously Treated) Females R-Therapy = Radiotherapy, C-Therapy = Chemotherapy ICD-9 Surgery (S) R-Therapy C-Therapy S+R S+C R+C S+R+C Others Unknown Total Site # % # % # % # % # % # % # % # % # % # % All